Skip to Content

Disclaimer

Disclaimer
MDS makes every effort to publish accurate information on the website. "Google Translate" is provided as a free tool for visitors to read content in one's native language. Translations are not guaranteed to be 100% accurate. Neither MDS nor its employees assume liability for erroneous translations of website content.

 

International Congress of Parkinson’s Disease and Movement Disorders ®

Congress
Main Content

Therapeutic Plenary Session 1102

Pharmacological Management of Parkinson’s Disease

Sunday, October 5, 2025
10:30 - 12:00 | Room TBD

In this session, the faculty will provide an evidence-based guide to pharmacological management of motor and key non-motor symptoms, as well as motor and non-motor fluctuations in Parkinson’s disease.


Chairs:

Andrew Siderowf, USA
Claudia Trenkwalder, Germany

Presenters:

Initial Management of Motor Symptoms
Shen-Yang Lim, Malaysia

Management of Key Non-Motor Symptoms
Melissa Armstrong, USA

Management of Motor and Non-Motor Fluctuations
Regina Katzenschlager, Austria

CSPC Liaisons:

Claudia Trenkwalder, Germany

Learning Objectives

At the conclusion of this session, participants should be better able to:

  1. Select initial pharmacological management of motor symptoms based on evidence of its impact on long-term outcomes
  2. Recognize and manage autonomic and cognitive dysfunction in Parkinson’s disease
  3. Discuss pharmacological options for motor and non-motor fluctuations in Parkinson’s disease

Recommended Audience

Clinician / General Neurology
Fellow / Resident / Student
Health Professional (non-physician)
Industry
Researcher / Basic Science

Education Level

Advanced / Expert
Beginner / Foundational
Intermediate / Experienced

Focus

Clinical